| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $351.4M | +0.0% |
| R&D Expense | $81.9M | -51.0% |
| SG&A Expense | $48.7M | +6.4% |
| Operating Income | -$130.7M | -194.4% |
| Pre-tax Income | -$119.5M | -186.2% |
| Income Tax | -$3.6M | -120.6% |
| Net Income | -$115.9M | -195.6% |
| EPS (Basic) | -$1.39 | -195.2% |
| EPS (Diluted) | -$1.39 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $188.5M | -75.3% |
| Current Assets | $660.9M | -14.4% |
| Total Assets | $666.7M | -13.7% |
| Current Liabilities | $18.5M | -67.5% |
| Total Liabilities | $26.1M | -58.4% |
| Stockholders' Equity | $640.6M | -9.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$121.0M | -39.1% |
| Capital Expenditures | $1.9M | — |
| Investing Cash Flow | -$455.4M | — |
| Financing Cash Flow | $370K | -74.7% |
| Free Cash Flow | -$122.9M | -41.3% |
| -201.5% |